EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical application of TBSRTC in thyroid FNAC: a single-center retrospective study

Yuanyuan Lei, Yanlin Wen, Aiwen Chen, Ya Gao, Jinhui Liu, Dongcun Wang

BMC Endocrine Disorders · 17.08.2026 · 26 (1)

DOI: 10.1186/s12902-026-02493-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Endocrine Disorders, online erschienen am 17.08.2026. Verfasst von Yuanyuan Lei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of …. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Nodule, Thyroid Gland, Cytodiagnosis. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanming Project of Medicine in Shenzhen, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Me…, Shenzhen High-level Hospital Construction Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thyroid fine-needle aspiration cytology (FNAC) classified according to the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is widely used for the preoperative evaluation of thyroid nodules. However, category distribution, observed risk of malignancy (ROM), and diagnostic performance may vary according to referral patterns, disease prevalence, and selective surgical follow-up.

Methods

This single-center retrospective study included 2,316 ultrasound-guided thyroid fine-needle aspiration (FNA) specimens from 1,791 patients evaluated at a tertiary cancer center between 2019 and 2022. Bethesda category distribution was assessed in the entire cohort. Observed ROM was calculated in 1,137 FNA sampling events with matched postoperative histopathology. Binary diagnostic performance was evaluated in 1,068 sampling events after exclusion of 42 category III and 27 category IV sampling events.

Results

Bethesda categories I–VI comprised 49 (2.1%), 762 (32.9%), 150 (6.5%), 89 (3.8%), 191 (8.2%), and 1,075 (46.4%) specimens, respectively. Among the 1,137 nodules with histopathologic follow-up, 156 were benign, 22 were borderline or low-risk neoplasms, and 959 were malignant. When borderline or low-risk neoplasms were classified as nonmalignant, the observed ROM values for categories I–VI were 50.0%, 20.5%, 61.9%, 37.0%, 84.2%, and 99.5%, respectively. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 95.6%, 90.0%, 94.9%, 98.6%, and 74.1%, respectively. False-negative diagnoses were predominantly associated with sampling limitations, including minute malignant foci, stromal fibrosis, thyroid follicular nodular disease, and cystic degeneration. False-positive diagnoses were mainly related to overlapping cytomorphologic features in reactive, inflammatory, hyperplastic, cystic, and treatment-related conditions.

Conclusions

Thyroid FNAC showed high diagnostic performance in this surgically selected tertiary cancer-center cohort. The observed ROM and predictive values were influenced by referral bias, surgical selection, and partial verification and should not be generalized to unselected thyroid FNA populations. Accurate targeting, representative sampling, cautious interpretation of focal atypia, and strict nodule-level cytology–histology correlation may reduce diagnostic discordance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid NoduleThyroid GlandCytodiagnosisHumansRetrospective StudiesFemaleMaleBiopsy, Fine-NeedleMiddle AgedAdultFollow-Up StudiesPrognosisAged

Stichwörter der Autor:innen

Bethesda SystemFalse-negative diagnosisFalse-positive diagnosisFine-needle aspiration cytologyRisk of malignancyThyroid

Autor:innen und Institutionen

  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 113 Baohe Avenue, L…

Förderung

  • Sanming Project of Medicine in Shenzhen
  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Me…
  • Shenzhen High-level Hospital Construction Fund

Zitieren

APA

Lei, Y., Wen, Y., Chen, A., Gao, Y., Liu, J., & Wang, D. (2026). Clinical application of TBSRTC in thyroid FNAC: a single-center retrospective study. BMC Endocrine Disorders, 26(1). https://doi.org/10.1186/s12902-026-02493-7

Vancouver

Lei Y, Wen Y, Chen A, Gao Y, Liu J, Wang D. Clinical application of TBSRTC in thyroid FNAC: a single-center retrospective study. BMC Endocrine Disorders. 2026;26(1). doi:10.1186/s12902-026-02493-7

BibTeX
@article{Lei2026,
  author = {Lei, Yuanyuan and Wen, Yanlin and Chen, Aiwen and Gao, Ya and Liu, Jinhui and Wang, Dongcun},
  title = {Clinical application of TBSRTC in thyroid FNAC: a single-center retrospective study},
  journal = {BMC Endocrine Disorders},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.1186/s12902-026-02493-7}
}
Kostenlos starten →